Clinical Trial Update: ROCOCO - Adaptive IMRT Versus IMPT in Head and Neck Cancer

View source ↗

Summary

The ROCOCO trial comparing adaptive IMRT versus IMPT for head and neck cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: Maastricht Radiation Oncology | Conditions: Head and Neck Neoplasms | Status: WITHDRAWN